“Medicaments que s’activen quan els toca la llum” (Eng)

Pau was interviewed for Barcelona’s leading daily newspaper following the June publication of his Angewandte Chemie paper, describing work carried out with colleagues from the IRB, that describes a strategy to quickly and reversibly impair the function of specific proteins using light-regulated inhibitory peptides. The paper was among the 5% to be included in the ‘Very Important Paper’ section of the journal, and has also been extensively publicised in the press both here and abroad.